This statistic depicts the total number of retail prescriptions filled annually in the United States from 2013 to 2025. It is estimated that in 2019, 4.38 billion retail prescriptions will be filled throughout the United States.U.S. Pharmacies and Drug Stores IndustryThe retail drug industry is comprised of pharmacies or drugstores, as they are known in North America. According to Statista estimates, which were calculated based on numbers presented by IBIS World, pharmacies and drugstores in the United States will generate a revenue of 257 billion U.S. dollars in 2014. With an aging population and greater prevalence of chronic diseases, the need for safe, legal pharmaceutical drugs is constantly rising.Pharmacies and drug stores dispense prescription medications and over-the-counter drugs directly to patients. However, their role is more than one of simple distribution as they dispense medication in specific doses, adhere to optimal conditions of storage and give valuable advice to patients. Pharmacies practice in a wide range of locations such as communities, hospitals, clinics and nursing homes. Other drug retail outlets include supermarkets, and independent and online pharmacies, which offer mail-order drugs to patients, proving especially convenient for those that may be unable to leave their homes. In 2016, CVS Health was the leading drug store chain in the United States, based on retail prescription sales, generating approximately 60.8 billion U.S. dollars. Apart from selling drugs, miscellaneous products also account for a percentage of sales for these retail outlets, such as cosmetics and confectioneries.The retail drug store industry employs many different types of workers. Each store has a manager, along with department managers or assistant managers to handle additional administrative duties. Sales associates are generally entry-level retail workers. Pharmacists require a specialized degree and licensing to dispense medication.

The number of prescriptions dispensed in the U.S. has increased between 2009 and 2022. In 2009 the number of prescriptions dispensed was near **** billion, while in 2022 the number of prescriptions dispensed was around *** billion. The increase in the number of prescriptions dispensed has a multifactorial origin that includes health care sources, health insurance, and prescription drug benefits. However, the increase in prescription drug usage comes with a price tag as the price of drugs in the U.S. is also on the rise. Medication usage The total number of retail prescriptions filed annually in the United States is expected to also rise significantly by the year 2025. Medication usage varies depending on the population, for example, some data shows that prescription usage increases with age. Likewise, gender has an influence on prescription drug use. Females have a higher rate of prescription drug usage. Prescription drug costs The U.S. has some of the highest per capita drug spending in the world. That is largely because the prices of drugs in the U.S. are based solely on what the market can bear, rather than what the actual costs of production are. Personal health care expenditures in the U.S. have more than doubled since 2000. Estimates suggest that the cost of drugs will continue to increase. Estimated U.S. prescribed drug expenditures amounted to *** billion U.S. dollars by the end of 2021.

In 2024, U.S.-based pharmacy retail company Walgreens filled about *** million prescriptions in the United States. These figures included vaccinations. In 2017, the number of prescriptions was *** million.

View quarterly trends in Risky Prescribing Measures, including: o Number/Rate of Individuals Seeing 5+ Prescribers and 5+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 4+ Prescribers and 4+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals Seeing 3+ Prescribers and 3+ Dispensers: Number of individuals who received prescriptions from 5 or more prescribers AND 5 or more dispensers for any Schedule II-V substance in a 3-month period. This measure is also referred to as Multiple Provider Episodes. County rates are calculated based on the patient’s county of residence. o Number/Rate of Individuals with an Average Daily MME >50, >90 or >120: Average Daily MME is calculated as the sum of the total MME on each day in a time period based on all prescriptions an individual has filled divided by the number of days in the prescription(s). Measures include the number and rate of individuals prescribed greater than 50 MME per day, greater than 90 MME per day, or greater than 120 MME per day and is based on the patient’s county of residence. o Number/Rate of Individuals with Overlapping Opioid/Benzodiazepine Prescriptions: Number of individuals receiving overlapping opioid and benzodiazepine prescriptions during a given quarter. This measure is based on the patients’ county of residence. o Number/Rate of Individuals with > 30 Days of Overlapping Opioid/Benzodiazepine Prescriptions: Number and rate of individuals receiving overlapping opioid and benzodiazepine prescriptions for 30 days or more during a given quarter using state/county populations as denominators. This measure is based on the patients’ county of residence. Please see PDMP Data Technical Notes for additional details: https://www.health.pa.gov/topics/programs/PDMP/Pages/Data.aspx

This report uses combined 2002 to 2013 National Survey on Drug Use and Health (NSDUH) to assess the average number of full-time college students aged 18 to 22 using substances for the first time per day for the year as a whole and for each month of the year. Substances examined include alcohol, cigarettes, cigars, marijuana, nonmedical use of prescription pain relievers, nonmedical use of prescription tranquilizers, nonmedical use of prescription stimulants, nonmedical use of prescription sedatives, inhalants, hallucinogens, and cocaine. Results are shown for each substance by month.

This bulletin presents a summary of prescriptions dispensed in the community by community pharmacists, appliance contractors and dispensing doctors in England. The bulletin highlights recent changes and the main trends between 2002 and 2012.

Dispensing Workflow refers to availability, use of and satisfaction with digital health tools/functions and the medication dispensing workflow.

BackgroundWhile the rise in opioid analgesic prescribing and overdose deaths was multifactorial, financial relationships between opioid drug manufacturers and physicians may be one important factor.MethodsUsing national data from 2013 to 2015, we conducted a retrospective cohort study linking the Open Payments database and Medicare Part D drug utilization data. We created two cohorts of physicians, those receiving opioid-related payments in 2014 and 2015, but not in 2013, and those receiving opioid-related payments in 2015 but not in 2013 and 2014. Our main outcome measures were expenditures on filled prescriptions, daily doses filled, and expenditures per daily dose. For each cohort, we created a comparison group that did not receive an opioid-related payment in any year and was matched on state, specialty, and baseline opioid expenditures. We used a difference-in-differences analysis with linear generalized estimating equations regression models.ResultsWe identified 6,322 physicians who received opioid-related payments in 2014 and 2015, but not in 2013; they received a mean total of $251. Relative to comparison group physicians, they had a significantly larger increase in mean opioid expenditures ($6,171; 95% CI: 4,997 to 7,346), daily doses dispensed (1,574; 95%CI: 1,330 to 1,818) and mean expenditures per daily dose ($0.38; 95% CI: 0.29 to 0.47). We identified 8,669 physicians who received opioid-related payments in 2015, but not in 2013 or 2014; they received a mean total of $40. Relative to comparison physicians, they also had a larger increase in mean opioid expenditures ($1,031; 95% CI: 603 to 1,460), daily doses dispensed (557; 95% CI: 417 to 697), and expenditures per daily dose ($0.06; 95% CI: 0.002 to 0.13).ConclusionsOur findings add to the growing public policy concern that payments from opioid drug manufacturers can influence physician prescribing. Interventions are needed to reduce such promotional activities or to mitigate their influence.

This statistic shows the percentage of the U.S. population with usage of prescription drugs within the past month between 1988 and 2018. In the period 2015-2018, **** percent of the population under 18 years used prescription drugs.

Abstract copyright UK Data Service and data collection copyright owner.The Health Survey for England (HSE) is a series of surveys designed to monitor trends in the nation's health. It was commissioned by NHS Digital and carried out by the Joint Health Surveys Unit of the National Centre for Social Research and the Department of Epidemiology and Public Health at University College London.The aims of the HSE series are:to provide annual data about the nation’s health;to estimate the proportion of people in England with specified health conditions;to estimate the prevalence of certain risk factors associated with these conditions;to examine differences between population subgroups in their likelihood of having specific conditions or risk factors;to assess the frequency with which particular combinations of risk factors are found, and which groups these combinations most commonly occur;to monitor progress towards selected health targetssince 1995, to measure the height of children at different ages, replacing the National Study of Health and Growth;since 1995, monitor the prevalence of overweight and obesity in children.The survey includes a number of core questions every year but also focuses on different health issues at each wave. Topics are revisited at appropriate intervals in order to monitor change. Further information about the series may be found on the NHS Digital Health Survey for England; health, social care and lifestyles webpage, the NatCen Social Research NatCen Health Survey for England webpage and the University College London Health and Social Surveys Research Group UCL Health Survey for England webpage. Changes to the HSE from 2015:Users should note that from 2015 survey onwards, only the individual data file is available under standard End User Licence (EUL). The household data file is now only included in the Special Licence (SL) version, released from 2015 onwards. In addition, the SL individual file contains all the variables included in the HSE EUL dataset, plus others, including variables removed from the EUL version after the NHS Digital disclosure review. The SL HSE is subject to more restrictive access conditions than the EUL version (see Access information). Users are advised to obtain the EUL version to see if it meets their needs before considering an application for the SL version. The Health Survey for England, 2017: Special Licence Access is available from the UK Data Archive under SN 9084.Latest edition information:For the third edition (May 2023), a number of corrections were made to the data file and the data documentation file. Further information is available in the documentation file '8488_hse_2017_eul_v3_corrections_to_ukds.pdf’. Main Topics: The data covers the following: Core topics: General health Longstanding illness Average weekly alcohol consumption Smoking Drinking (heaviest day in last week) Fruit and vegetable consumption Consent to data linkage (NHS central register, HES) Socio-economic information: sex, age, income, education, employment etc Prescribed medications (nurse) Additional topics: Physical activity (adults) Social care receipt and provision Cardiovascular Diseases Chronic Pain End of Life Care Measurements: Height and weight Blood pressure (nurse) Waist and hip circumference (nurse) Blood sample for cholesterol, glycated haemoglobin (nurse) Saliva sample (nurse) Multi-stage stratified random sample Self-administered questionnaire: Computer-assisted (CASI) Physical measurements and tests Clinical measurements Face-to-face interview: Computer-assisted (CAPI/CAMI) 2017 2018 ADDICTION AGE ALCOHOL USE ALCOHOLIC DRINKS ALLERGIES ANTHROPOMETRIC DATA ANXIETY ASTHMA BACTERIAL AND VIRUS... BEDROOMS BIRTH CONTROL BIRTH WEIGHT BODY CIRCUMFERENCE ... BRONCHIAL DISEASES CANCER CARDIOVASCULAR DISE... CARE OF THE ELDERLY CARS CEREAL PRODUCTS CHILDREN CHRONIC ILLNESS CLINICAL TESTS AND ... COHABITATION CONCENTRATION CONTRACEPTIVE DEVICES CYCLING DEBILITATIVE ILLNESS DENTAL CARE DENTAL HEALTH DEPRESSION DIABETES DIGESTIVE SYSTEM DI... DRINKING BEHAVIOUR ECONOMIC ACTIVITY EDUCATIONAL BACKGROUND EMOTIONAL STATES EMPLOYEES EMPLOYMENT EMPLOYMENT HISTORY ENDOCRINE DISORDERS ETHNIC GROUPS EYESIGHT TESTS England FAMILY MEMBERS FOOD FOOD AND NUTRITION FOOD SUPPLEMENTS FRUIT FULL TIME EMPLOYMENT FURNISHED ACCOMMODA... GAMBLING GAMBLING LOSSES GENDER General health and ... HAPPINESS HEADS OF HOUSEHOLD HEALTH HEALTH ADVICE HEALTH CONSULTATIONS HEALTH PROFESSIONALS HEARING IMPAIRMENTS HEART DISEASES HEIGHT PHYSIOLOGY HOUSEHOLD INCOME HOUSEHOLDS HOUSING BENEFITS HOUSING CONDITIONS HOUSING TENURE Health Health behaviour Health care service... ILL HEALTH INCOME INFLUENZA INFORMAL CARE INFORMATION SOURCES INTERNET GAMBLING JOB HUNTING JOB SEEKER S ALLOWANCE JOINT DISEASES LANDLORDS LEGUMES LIVER DISEASES LUNG DISEASES MANAGERS MARITAL STATUS MEDICAL CARE MEDICAL PRESCRIPTIONS MEDICINAL DRUGS MENTAL DISORDERS MENTAL HEALTH MENTAL HEALTH ATTIT... MOTOR VEHICLES MUSCULOSKELETAL SYSTEM NERVOUS SYSTEM DISE... NURSES OBESITY OCCUPATIONAL QUALIF... PART TIME EMPLOYMENT PASSIVE SMOKING PENSION BENEFITS PENSIONS PHYSICAL ACTIVITIES PHYSICAL MOBILITY PHYSICIANS PREGNANCY PREMATURE BIRTHS PRESCRIPTION DRUGS PRESERVED FOODS QUALIFICATIONS RENTED ACCOMMODATION RESPIRATORY TRACT D... RESPIRATORY TRACT I... SELF EMPLOYED SELF ESTEEM SEXUAL HEALTH SHIFT WORK SIGHT SKIN DISEASES SMOKING SMOKING CESSATION SOCIAL CLASS SOCIAL SECURITY BEN... SOCIAL SUPPORT SOCIO ECONOMIC STATUS STATE RETIREMENT PE... STATUS IN EMPLOYMENT SUPERVISORY STATUS Social behaviour an... TOBACCO UNFURNISHED ACCOMMO... UROLOGIC DISEASES VASCULAR DISEASES VEGETABLES VISION IMPAIRMENTS WEIGHT CONTROL WEIGHT PHYSIOLOGY WELL BEING SOCIETY